Patents by Inventor Frédéric Charbonnier

Frédéric Charbonnier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NON-MAGNETIC TIMEPIECE PARTS AND THERMOMECHANICAL TREATMENT METHOD FOR OBTAINING SAID PARTS
    Publication number: 20240043951
    Abstract: A non-magnetic part including an austenitic alloy, the austenitic alloy including between 50 and 85 wt % of iron, one or more gammagene elements the weight percentage or the total weight percentages of which amount to between 15 and 35 wt %, and less than 2 wt % of nitrogen. The austenitic alloy has a crystallographic structure including a predominantly cubic crystal structure and the presence of a hexagonal crystal structure. The magnetic part includes a hardness gradient in the direction extending radially from the surface of the at least one portion of the non-magnetic part to the inside of the non-magnetic part, the hardness gradient having a value greater than or equal to 100 HV.
    Type: Application
    Filed: December 22, 2021
    Publication date: February 8, 2024
    Inventors: Pascal LAHEURTE, Pierre Frédéric CHARBONNIER, Gael LE COZ
  • ERK inhibitors for use in treating spinal muscular atrophy
    Patent number: 9833439
    Abstract: The present invention relates to a method for treating spinal muscular atrophy and other related neuromuscular disorders in a subject in need thereof, said method comprising administering a therapeutically effective amount of an ERK inhibitor, such as Selumetinib to said subject.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: December 5, 2017
    Assignees: UNIVERSITE PARIS DESCARTES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Frédéric Charbonnier, Olivier Biondi
  • ERK INHIBITORS FOR USE IN TREATING SPINAL MUSCULAR ATROPHY
    Publication number: 20140113956
    Abstract: The present invention relates to a method for treating spinal muscular atrophy and other related neuromuscular disorders in a subject in need thereof, said method comprising administering a therapeutically effective amount of an ERK inhibitor, such as Selumetinib to said subject.
    Type: Application
    Filed: May 24, 2012
    Publication date: April 24, 2014
    Applicant: UNIVERSITE PARIS DESCARTES
    Inventors: Frédéric Charbonnier, Olivier Biondi